Scientists at Queen Mary University of London recently revealed a breakthrough with a new experimental drug called Rapalink-1.
This drug targets a key cellular pathway that controls growth, extending yeast cell lifespan and delaying signs of aging.
Unexpectedly, the study also uncovered a role for enzymes called agmatinases in maintaining the balance of this pathway.
This finding could open new doors for developing anti-aging therapies in humans in the future.
Meanwhile, separate research from King’s College London highlights the heart health benefits of phenolic-rich foods.
Regular consumption of tea, coffee, berries, and whole grains was linked to lower blood pressure and healthier cholesterol levels.
Over a decade-long study, participants who ate these foods consistently had reduced estimated cardiovascular risk.
This suggests that small daily dietary choices can have a profound impact on long-term heart health.
Combining scientific innovations like Rapalink-1 with everyday healthy eating could redefine how we approach longevity.
While drugs may help slow cellular aging, nutrition remains a powerful tool for overall well-being.
.jpg)
0 Comments